Lim Sangyi, Park Min-Jung, Yoon Ki-Nam, Lee Junhyeong, Matienzo Merc Emil, Hong Seong-Jin, Kim Keon, Baek Yeong-Bin, Lee Chang-Min, Kim Young-Min, Park Bu-Soo, Kim Dong-Il
Department of Veterinary Physiology, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Republic of Korea.
College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju 61186, Republic of Korea.
Food Chem X. 2025 Jun 19;29:102679. doi: 10.1016/j.fochx.2025.102679. eCollection 2025 Jul.
As concerns about sugar-sweetened beverages are increasing, interest in natural sweeteners with zero calories is also growing. This study explores the health impacts of rebaudioside D and M, emerging sugar substitutes, compared to traditional alternatives and stevioside. In mouse models, we investigated the effects of rebaudioside D and M on obesity, liver health, thermogenic adipocytes, skeletal muscle, and gut microbiota. Results show no weight gain or exacerbation of obesity, no promotion of hepatic steatosis, no impairment of brown adipose tissue function and no changes in skeletal muscle metabolic proteins with either rebaudioside. Importantly, both of these sugar substitutes positively influence gut microbiota without adverse metabolic effects, suggesting their potential as safe sugar alternatives.
随着对含糖饮料的担忧日益增加,对零热量天然甜味剂的兴趣也在不断增长。本研究探讨了莱鲍迪苷D和M这两种新兴糖替代品与传统替代品及甜菊糖苷相比对健康的影响。在小鼠模型中,我们研究了莱鲍迪苷D和M对肥胖、肝脏健康、产热脂肪细胞、骨骼肌和肠道微生物群的影响。结果显示,使用这两种莱鲍迪苷均未出现体重增加或肥胖加剧、未促进肝脂肪变性、未损害棕色脂肪组织功能,且骨骼肌代谢蛋白也未发生变化。重要的是,这两种糖替代品均对肠道微生物群有积极影响,且无不良代谢效应,表明它们有潜力成为安全的糖替代品。